Roche to buy molecular diagnostics company IQuum PDF  | Print |  E-mail
Written by Associated Press   
Monday, 07 April 2014 06:29

GENEVA (AP) — Swiss drug maker Roche plans to buy IQuum, Inc., a U.S. company that specializes in molecular diagnostics and sample testing, in a deal worth up to $450 million.

Roche said Monday that it will pay $275 million upfront for the privately held IQuum, based in Marlborough, Massachusetts. It said further payments of up to $175 million are dependent on "product-related milestones."

Once the acquisition is complete, Roche plans to integrate IQuum into its Roche Molecular Diagnostics division.


Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 

Front Page Stories

Body of BGSU student found
07/23/2014 | Sentinel-Tribune Staff
article thumbnail

A missing poster for Cory Barron, is posted on a light pole along West 6th Street in Cle [ ... ]


Chinese lanterns may have ignited fire
07/23/2014 | PETER KUEBECK, Sentinel Staff Writer
article thumbnail

File photo. A firefighter is seen near a fire engulfing a pallet yard on West Broadway S [ ... ]


Other Front Page Articles